What Gene Sequencer is Roche (RHHBY) Aiming to Buy? (ILMN) (GENE)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- S&P 500 ends marginally lower as investors focus on US-Iran war
Roche Prepared to Pay $66/Share for Illumina (ILMN) - Reports
December 20, 2012 6:57 AM ESTIllumina, Inc. (NASDAQ: ILMN) is on watch Thursday following reports from L'Agefi that Roche has agreed to pay $66 per share for the company although a deal has not been finalized.
Illumina rejected a $51 per share bid from Roche in April 2012. Roche... More
Roche (RHHBY) May Use Cash to Reduce Debt, Make Acquisitions - CFO Hippe
December 20, 2012 6:11 AM ESTRoche (OTCBB: RHHBY) plans to make acquisitions in the $6 billion to $7 billion range, according to CFO Alan Hippe.
The firm is targeting technologies, including gene sequencing, and it might buy smaller, complimentary firms.
Roche plans to reduce debt to... More
